EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma

Wei Hao, Qingchen Zhang, Yuan Ma, Yue Ding, Chunling Zhao, Chunyan Tian

Journal of Molecular Medicine · 2025

DOI: 10.1007/s00109-025-02532-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Medicine, 2025. Verfasst von Wei Hao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Shandong Second Medical University, Weifang, 261053, Shandong Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Histone Deacetylase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoma is the sixth most malignant tumor in the world and the second leading cause of cancer death. Among the types of hepatoma, hepatocellular carcinoma (HCC) is the most important pathological type. For patients with early-stage HCC, the curative treatment is tumor resection. However, early diagnosis and treatment of HCC are difficult; the disease progresses rapidly, and the prognosis is poor. Due to the current limited treatment options for advanced HCC, the identification of new targeted agents is critical for the development of novel approaches to HCC treatment. Histone deacetylases (HDACs) is a protease that removes acetyl groups from histone lysine residues in proteins, and it plays an important role in the structural modification of chromosomes and the regulation of gene expression. Abnormally expressed HDACs can promote tumorigenesis by inducing biological processes such as cell proliferation, migration, and apoptosis inhibition. Since HDACs activity is upregulated in HCC, treatment regimens specifically inhibiting various HDACs have shown good efficacy. This article reviews the application of HDAC inhibitors in the treatment of HCC and explains their mechanisms of action. KEY MESSAGES: HDAC network and cellular effects of HDAC inhibitors. Role and mechanism of HDAC inhibitors in HCC. HDAC inhibitor combined with other ways to treat HCC. The side effects of HDACis in the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHistone Deacetylase InhibitorsAntineoplastic AgentsHumansHistone DeacetylasesAnimalsCell ProliferationApoptosis

Stichwörter der Autor:innen

HCCHDAC inhibitorsHDACsTarget drug

Substanzen

Histone Deacetylase InhibitorsHistone DeacetylasesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Life Science and Technology, Shandong Second Medical University, Weifang, 261053, Shandong Province, China.
  • State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, 102206, China.
  • Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, Shandong Second Medical University, Weifang, 261053, Shandong Province, China.
  • School of Life Science and Technology, Shandong Second Medical University, Weifang, 261053, Shandong Province, China. zhaochunlingbj@163.com.
  • Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, Shandong Second Medical University, Weifang, 261053, Shandong Province, China. zhaochunlingbj@163.com.
  • State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, 102206, China. tianchunyan@ncpsb.org.cn.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Hao, W., Zhang, Q., Ma, Y., Ding, Y., Zhao, C., & Tian, C. (2025). Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-025-02532-1

Vancouver

Hao W, Zhang Q, Ma Y, Ding Y, Zhao C, Tian C. Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma. Journal of Molecular Medicine. 2025. doi:10.1007/s00109-025-02532-1

BibTeX
@article{Hao2025,
  author = {Hao, Wei and Zhang, Qingchen and Ma, Yuan and Ding, Yue and Zhao, Chunling and Tian, Chunyan},
  title = {Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma},
  journal = {Journal of Molecular Medicine},
  year = {2025},
  doi = {10.1007/s00109-025-02532-1}
}
Kostenlos starten →